A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

besthealthtale.com
Home ยป
A significant number of non-Hodgkin lymphoma (NHL) patients in a Penn Medicine-initiated clinical trial continue to be in remission five
Diversity is good, especially when it comes to antibodies. It’s long been known that a gene assembly process called V(D)J
CAR T-cell therapy, a rapidly emerging form of immunotherapy using patients’ own cells to treat certain types of cancers, may
Rice University scientists have found a way to engineer a new kind of cell differentiation in bacteria, inspired by a
Scientists have presented new findings that challenge established concepts of genetic inheritance. They have proven that somatic cells of the
Being able to identify targets for adoptive cell therapies is one of the first steps in developing personalized treatments for
A new study from Iowa State University entomologists describes how mosquitoes fight off parasites that cause malaria, a disease that
Cancer cells use a bizarre strategy to reproduce in a tumor’s low-energy environment; they mutilate their own mitochondria! Researchers at
For cancer to be successful — from its point of view, anyway — the disease has to find a way
Researchers at The Westmead Institute for Medical Research have discovered brand new immune cells that are at the frontline of